Entities / Company
TenX.
A human centered design and technology studio.
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
TenX experienced a clinical trial failure on August 12, 2026, causing a drop in its stock value.Some support1 report
-
TenX plans to consult both the FDA and EMA regarding the results of its clinical trials.Some support1 report
-
William Blair reissued an outperform rating for TenX, while Cantor Fitzgerald reaffirmed an overweight rating on July 3, 2026.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around TenX this week
News at the entities that move TenX most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves TenX
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves TenX
-
Cantor Fitzgerald Mentioned togetherAnalyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Moves TenX
-
William P. Blair Mentioned togetherWatsco reported margin impacts due to subdued international sales in Mexico, with analysts questioning volume trends.Moves TenX
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves TenX
-
MarketBeat Mentioned togetherMarketBeat aggregates data on IDT Corporation stock performance.Moves TenX
Connections
The 7 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SEC Structural
TenX is subject to SEC regulatory requirements, mandating the filing of specific transactions.
-
FDA Structural
TenX engages with the FDA for regulatory reviews and consultations regarding its drug development plans and trial results.
-
Nasdaq Structural
TenX is a company whose stock is listed and trades on the Nasdaq stock exchange.
-
MarketBeat Mentioned together
MarketBeat functions as a major information aggregator and publisher of news and analyst ratings for TenX.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provided an overweight rating on TenX.
-
EMA Structural
The company plans to consult EMA regarding the outcomes of its clinical trials.
-
William P. Blair Mentioned together
William Blair issued an outperform rating on TenX.